TetraLogic Pharmaceuticals Corp (TLOG)
0.00
USD |
OTCM |
May 03, 16:00
TetraLogic Pharmaceuticals Cash from Investing (TTM): 13.78M for Sept. 30, 2016
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| September 30, 2016 | 13.78M |
| June 30, 2016 | 22.48M |
| March 31, 2016 | 28.80M |
| December 31, 2015 | 35.45M |
| September 30, 2015 | 34.29M |
| June 30, 2015 | 10.26M |
| Date | Value |
|---|---|
| March 31, 2015 | -13.59M |
| December 31, 2014 | -53.98M |
| September 30, 2014 | -61.37M |
| June 30, 2014 | -46.05M |
| March 31, 2014 | -28.53M |
| December 31, 2013 | -0.0673M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.019M |
| Palatin Technologies Inc | 9.293M |
| iBio Inc | 8.285M |
| Theriva Biologics Inc | -0.202M |
| Oragenics Inc | -0.9363M |